• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurv. Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons

tetano

Editor, Senior Moderator
Euro Surveill. 2019 Feb;24(6). doi: 10.2807/1560-7917.ES.2019.24.6.1800467.
[h=1]Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons.[/h] Kawakami C[SUP]1[/SUP], Yamayoshi S[SUP]2[/SUP], Akimoto M[SUP]3[/SUP], Nakamura K[SUP]3[/SUP], Miura H[SUP]3[/SUP], Fujisaki S[SUP]3[/SUP], Pattinson DJ[SUP]4[/SUP], Shimizu K[SUP]1[/SUP], Ozawa H[SUP]1[/SUP], Momoki T[SUP]1[/SUP], Saikusa M[SUP]1[/SUP], Yasuhara A[SUP]2[/SUP], Usuku S[SUP]1[/SUP], Okubo I[SUP]1[/SUP], Toyozawa T[SUP]5[/SUP], Sugita S[SUP]6[/SUP], Smith DJ[SUP]4[/SUP], Watanabe S[SUP]3[/SUP], Kawaoka Y[SUP]7,[/SUP][SUP]8,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza A(H3N2) virus rapidly evolves to evade human immune responses, resulting in changes in the antigenicity of haemagglutinin (HA). Therefore, continuous genetic and antigenic analyses of A(H3N2) virus are necessary to detect antigenic mutants as quickly as possible.
[h=4]AIM:[/h] We attempted to phylogenetically and antigenically capture the epidemic trend of A(H3N2) virus infection in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons.
[h=4]METHODS:[/h] We determined the HA sequences of A(H3N2) viruses detected in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons to identify amino acid substitutions and the loss or gain of potential N-glycosylation sites in HA, both of which potentially affect the antigenicity of HA. We also examined the antigenicity of isolates using ferret antisera obtained from experimentally infected ferrets.
[h=4]RESULTS:[/h] Influenza A(H3N2) viruses belonging to six clades (clades 3C.2A1, 3C.2A1a, 3C.2A1b, 3C.2A2, 3C.2A3 and 3C.2A4) were detected during the 2016/17 influenza season, whereas viruses belonging to two clades (clades 3C.2A1b and 3C.2A2) dominated during the 2017/18 influenza season. The isolates in clades 3C.2A1a and 3C.2A3 lost one N-linked glycosylation site in HA relative to other clades. Antigenic analysis revealed antigenic differences among clades, especially clade 3C.2A2 and 3C.2A4 viruses, which showed distinct antigenic differences from each other and from other clades in the antigenic map.
[h=4]CONCLUSION:[/h] Multiple clades, some of which differed antigenically from others, co-circulated in Yokohama, Japan during the 2016/17 and 2017/18 influenza seasons.


[h=4]KEYWORDS:[/h] H3N2; HA; Japan; antigenicity; epidemiology; glycosylation; haemagglutinin; influenza; influenza virus; surveillance; viral infections

PMID: 30755292 DOI: 10.2807/1560-7917.ES.2019.24.6.1800467
Free full text
 
Back
Top Bottom